The IDG PT-HS reagent is an in vitro diagnostic assay intended for use in performing the one stage prothrombin time (PT) test and assays which are based on a modified prothrombin time.

Calcium Chloride 0.020 M is a reagent for use only in the in vitro determination of Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and recalcification (plasma clotting) time, as well as in various coagulation factor assays

STAT PROFILE pHOx/BASIC/PLUS/L/C REFERENCE LINE ASSEMBLY

STAT PROFILE pHOx/BASIC/PLUS/L/C SENSOR

STAT PROFILE pHOx/BASIC/PLUS/L/C FLUSH FIXTURE

Stat Profile CCX Stat Profile pHOx/Basic/Plus/L/C/M Control Flush Fixture

Stat Profile pHOx Plus Analyzer

STAT PROFILE pHOx PLUS SENSOR MODULE REPLACEMENT

Remanufactured Stat Profile pHOx Plus Analyzer

Stat Profile pHOx Plus L Analyzer

STAT PROFILE pHOx PLUS/C PROBE

Remanufactured Stat Profile pHOx Plus L Analyzer

Stat Profile pHOx Plus Air Detector

CoaguChek Vantus (USA)

The Xprecia Stride™ Coagulation System is intended for use by professional healthcare providers to provide an INR (InternationalNormalized Ratio) based on a Prothrobin time (PT) response for the monitoring of oral anticoagulation therapy with Warfarin.

Xprecia™ System PT/INR Strips, is intended for use by professional healthcare providers to provide an INR (International NormalizedRatio) based on a prothrombin time (PT) response for the monitoring of oral anticoagulation therapy with warfarin

Determination of prothrombin time (PT) and of the activity of coagulation factors II, V, VII and X

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma

Determination of prothrombin time (PT) and of the activity of coagulation factors II, V, VII and X

Determination of prothrombin time (PT) and of the activity of coagulation factors II, V, VII and X

Determination of prothrombin time (PT) and of the activity of coagulation factors II, V, VII and X

Determination of prothrombin time (PT) and of the activity of coagulation factors II, V, VII and X

The Xprecia Prime™ Coagulation System, which includes the INR Coagulation Analyzer (Meter) and PT/INR Test Strips, is for the determination of International Normalized Ratio (INR) for the monitoring of oral anticoagulation therapy with Warfarin (a vitamin K antagonist) in fresh capillary whole blood from a fingerstick. The results are reported in INR as well as in seconds. It is intended to be used to monitor patients 18 years of age or older who are stable on vitamin K antagonist therapy for at least six weeks and is not intended for use in patients who are transitioning from heparin treatment to vitamin K antagonist therapy. The Xprecia Prime™ Coagulation System is an in-vitro diagnostic device intended for multi-patient use in professional healthcare settings including CLIA Waived and Point of care settings.

The Xprecia Prime™ Coagulation System, which includes the INR Coagulation Analyzer (Meter) and PT/INR Test Strips, is for the determination of International Normalized Ratio (INR) for the monitoring of oral anticoagulation therapy with Warfarin (a vitamin K antagonist) in fresh capillary whole blood from a fingerstick. The results are reported in INR as well as in seconds. It is intended to be used to monitor patients 18 years of age or older who are stable on vitamin K antagonist therapy for at least six weeks and is not intended for use in patients who are transitioning from heparin treatment to vitamin K antagonist therapy. The Xprecia Prime™ Coagulation System is an in-vitro diagnostic device intended for multi-patient use in professional healthcare settings including CLIA Waived and Point of care settings.